{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:19:10Z","timestamp":1794050350631,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Metastasis is a leading cause of treatment failure and high mortality in non-small cell lung cancer (NSCLC). Recently, we demonstrated that DEAD box helicase 39B (DDX39B) was upregulated and activated metabolic reprogramming in colorectal cancer and hepatocellular carcinoma. However, the function of DDX39B and the therapeutic potential for targeting DDX39B in NSCLC remain unclear. Herein, we discovered that DDX39B was an independent marker for poor survival in NSCLC patients. Strikingly, DDX39B protein, but not its mRNA, was elevated in clinical metastatic brain lesions and metastatic cell models (in vitro EMT-metastatic and in vivo carotid artery injection-induced brain-metastatic cell model). Mechanistically, DDX39B interacted with E3 ubiquitin ligase TRIM28 via Pro322 residue and underwent TRIM28-mediated K63-linked ubiquitination at Lys241, Lys384, and Lys398, leading to DDX39B protein stabilization and upregulation. Subsequently, DDX39B directly bound to ECAD and promoted ECAD lysosomal degradation by recruiting Src and Hakai, which was independent of its RNA helicase activity, followed by activating \u03b2-catenin oncogenic signaling and facilitating NSCLC aggressive phenotype. According to structure-based virtual screening, we discovered a clinical antimalarial drug, artesunate, that disrupted the association of DDX39B-TRIM28 complex, resulting in DDX39B degradation and blocking the pro-metastatic effects of DDX39B. Overall, our findings uncover that TRIM28\/DDX39B\/ECAD axis contributes to NSCLC metastasis and targeting DDX39B degradation by artesunate is an effective and promising therapeutic approach for the treatment of NSCLC.<\/jats:p>","DOI":"10.1038\/s41392-025-02305-9","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:03:19Z","timestamp":1752620599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["DDX39B K63-linked ubiquitination mediated by TRIM28 promotes NSCLC metastasis by enhancing ECAD lysosomal degradation"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-4334","authenticated-orcid":false,"given":"Hang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8982-8397","authenticated-orcid":false,"given":"Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"2305_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA-Cancer J. Clin. 72, 7\u201333 (2022).","journal-title":"CA-Cancer J. Clin."},{"key":"2305_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F. & Wong, K. K. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat. Rev. Cancer 14, 535\u2013546 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"2305_CR3","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1097\/CM9.0000000000002127","volume":"135","author":"W Liu","year":"2022","unstructured":"Liu, W., Powell, C. A. & Wang, Q. Tumor microenvironment in lung cancer-derived brain metastasis. Chin. Med. J. 135, 1781\u20131791 (2022).","journal-title":"Chin. Med. J."},{"key":"2305_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13402-017-0345-5","volume":"40","author":"M Yousefi","year":"2017","unstructured":"Yousefi, M. et al. Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options. Cell. Oncol. 40, 419\u2013441 (2017).","journal-title":"Cell. Oncol."},{"key":"2305_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.canlet.2018.09.033","volume":"442","author":"K Li","year":"2019","unstructured":"Li, K. et al. ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src\/FAK signaling in hepatocellular carcinoma. Cancer Lett. 442, 271\u2013278 (2019).","journal-title":"Cancer Lett."},{"key":"2305_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274\u2013284 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"2305_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko, I. et al. Identification of the tumour transition states occurring during EMT. Nature 556, 463\u2013468 (2018).","journal-title":"Nature"},{"key":"2305_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. Emt: 2016. Cell 166, 21\u201345 (2016).","journal-title":"Cell"},{"key":"2305_CR9","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1101\/gad.336024.119","volume":"34","author":"C Perez-Calero","year":"2020","unstructured":"Perez-Calero, C. et al. UAP56\/DDX39B is a major cotranscriptional RNA-DNA helicase that unwinds harmful R loops genome-wide. Genes Dev. 34, 898\u2013912 (2020).","journal-title":"Genes Dev."},{"key":"2305_CR10","doi-asserted-by":"publisher","first-page":"168604","DOI":"10.1016\/j.jmb.2024.168604","volume":"436","author":"R Yellamaty","year":"2024","unstructured":"Yellamaty, R. & Sharma, S. Critical Cellular Functions and Mechanisms of Action of the RNA Helicase UAP56. J. Mol. Biol. 436, 168604 (2024).","journal-title":"J. Mol. Biol."},{"key":"2305_CR11","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/15476286.2018.1517011","volume":"15","author":"S Awasthi","year":"2018","unstructured":"Awasthi, S. et al. DDX39B promotes translation through regulation of pre-ribosomal RNA levels. RNA Biol. 15, 1157\u20131166 (2018).","journal-title":"RNA Biol."},{"key":"2305_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s11033-024-09912-9","volume":"51","author":"S Li","year":"2024","unstructured":"Li, S. et al. DEAD-box RNA helicases in the multistep process of tumor metastasis. Mol. Biol. Rep. 51, 1006 (2024).","journal-title":"Mol. Biol. Rep."},{"key":"2305_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1628","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. m(6)A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia. Clin. Transl. Med. 14, e1628 (2024).","journal-title":"Clin. Transl. Med."},{"key":"2305_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s13402-023-00807-8","volume":"46","author":"T Feng","year":"2023","unstructured":"Feng, T. et al. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis. Cell. Oncol. 46, 1235\u20131252 (2023).","journal-title":"Cell. Oncol."},{"key":"2305_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13046-022-02490-3","volume":"41","author":"Q Tu","year":"2022","unstructured":"Tu, Q. et al. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma. J. Exp. Clin. Cancer Res. 41, 274 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2305_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12929-017-0374-4","volume":"24","author":"P Czerwinska","year":"2017","unstructured":"Czerwinska, P., Mazurek, S. & Wiznerowicz, M. The complexity of TRIM28 contribution to cancer. J. Biomed. Sci. 24, 63 (2017).","journal-title":"J. Biomed. Sci."},{"key":"2305_CR17","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41388-024-03167-1","volume":"43","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progression. Oncogene 43, 3255\u20133267 (2024).","journal-title":"Oncogene"},{"key":"2305_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41392-023-01450-3","volume":"8","author":"X Ma","year":"2023","unstructured":"Ma, X. et al. TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Signal. Transduct. Target. Ther. 8, 246 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"2305_CR19","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1038\/s41418-020-00701-y","volume":"28","author":"JO Jin","year":"2021","unstructured":"Jin, J. O. et al. Sequential ubiquitination of p53 by TRIM28, RLIM, and MDM2 in lung tumorigenesis. Cell Death Differ. 28, 1790\u20131803 (2021).","journal-title":"Cell Death Differ."},{"key":"2305_CR20","doi-asserted-by":"publisher","first-page":"40106","DOI":"10.1074\/jbc.M112.380865","volume":"287","author":"L Chen","year":"2012","unstructured":"Chen, L. et al. Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1\/E2F interactions. J. Biol. Chem. 287, 40106\u201340118 (2012).","journal-title":"J. Biol. Chem."},{"key":"2305_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40793-x","volume":"14","author":"A Skakodub","year":"2023","unstructured":"Skakodub, A. et al. Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. Nat. Commun. 14, 4980 (2023).","journal-title":"Nat. Commun."},{"key":"2305_CR22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/jcmm.17150","volume":"26","author":"Q Guo","year":"2022","unstructured":"Guo, Q. et al. Enhanced nuclear localization of YAP1-2 contributes to EGF-induced EMT in NSCLC. J. Cell. Mol. Med. 26, 1013\u20131023 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"2305_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jhep.2014.03.033","volume":"61","author":"A Claperon","year":"2014","unstructured":"Claperon, A. et al. EGF\/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. J. Hepatol. 61, 325\u2013332 (2014).","journal-title":"J. Hepatol."},{"key":"2305_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13045-021-01045-x","volume":"14","author":"M Yi","year":"2021","unstructured":"Yi, M. et al. The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-beta and PD-L1. J. Hematol. Oncol. 14, 27 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"2305_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527, 100\u2013104 (2015).","journal-title":"Nature"},{"key":"2305_CR26","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gkx1041","volume":"46","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. iUUCD 2.0: an update with rich annotations for ubiquitin and ubiquitin-like conjugations. Nucleic Acids Res. 46, D447\u2013D453 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2305_CR27","doi-asserted-by":"publisher","first-page":"103350","DOI":"10.1016\/j.redox.2024.103350","volume":"76","author":"X Xie","year":"2024","unstructured":"Xie, X. et al. Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors. Redox Biol. 76, 103350 (2024).","journal-title":"Redox Biol."},{"key":"2305_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molcel.2016.09.014","volume":"64","author":"F Ohtake","year":"2016","unstructured":"Ohtake, F., Saeki, Y., Ishido, S., Kanno, J. & Tanaka, K. The K48-K63 Branched Ubiquitin Chain Regulates NF-kappaB Signaling. Mol. Cell 64, 251\u2013266 (2016).","journal-title":"Mol. Cell"},{"key":"2305_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-10-23","volume":"10","author":"H Walczak","year":"2012","unstructured":"Walczak, H., Iwai, K. & Dikic, I. Generation and physiological roles of linear ubiquitin chains. BMC Biol. 10, 23 (2012).","journal-title":"BMC Biol."},{"key":"2305_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery, J. P. & Sleeman, J. P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131\u2013142 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2305_CR31","doi-asserted-by":"publisher","first-page":"118472","DOI":"10.1016\/j.bbamcr.2019.04.002","volume":"1866","author":"H Huang","year":"2019","unstructured":"Huang, H., Wright, S., Zhang, J. & Brekken, R. A. Getting a grip on adhesion: Cadherin switching and collagen signaling. Biochim. Biophys. Acta-Mol. Cell Res. 1866, 118472 (2019).","journal-title":"Biochim. Biophys. Acta-Mol. Cell Res."},{"key":"2305_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ncb758","volume":"4","author":"Y Fujita","year":"2002","unstructured":"Fujita, Y. et al. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4, 222\u2013231 (2002).","journal-title":"Nat. Cell Biol."},{"key":"2305_CR33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/emboj.2011.496","volume":"31","author":"M Mukherjee","year":"2012","unstructured":"Mukherjee, M. et al. Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin. EMBO J. 31, 1308\u20131319 (2012).","journal-title":"EMBO J."},{"key":"2305_CR34","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1083\/jcb.201706013","volume":"217","author":"C Gayrard","year":"2018","unstructured":"Gayrard, C., Bernaudin, C., Dejardin, T., Seiler, C. & Borghi, N. Src- and confinement-dependent FAK activation causes E-cadherin relaxation and beta-catenin activity. J. Cell Biol. 217, 1063\u20131077 (2018).","journal-title":"J. Cell Biol."},{"key":"2305_CR35","doi-asserted-by":"publisher","first-page":"22544","DOI":"10.1074\/jbc.M702304200","volume":"282","author":"J Shen","year":"2007","unstructured":"Shen, J., Zhang, L. & Zhao, R. Biochemical characterization of the ATPase and helicase activity of UAP56, an essential pre-mRNA splicing and mRNA export factor. J. Biol. Chem. 282, 22544\u201322550 (2007).","journal-title":"J. Biol. Chem."},{"key":"2305_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2305_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7108a1","volume":"71","author":"KE Mace","year":"2022","unstructured":"Mace, K. E., Lucchi, N. W. & Tan, K. R. Malaria Surveillance - United States, 2018. MMWR Surv. Summ. 71, 1\u201335 (2022).","journal-title":"MMWR Surv. Summ."},{"key":"2305_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41392-022-01096-7","volume":"7","author":"G Zhao","year":"2022","unstructured":"Zhao, G. et al. DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. Signal. Transduct. Target. Ther. 7, 275 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"2305_CR39","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s11033-011-0940-x","volume":"39","author":"F Xiong","year":"2012","unstructured":"Xiong, F. et al. Plk1-mediated phosphorylation of UAP56 regulates the stability of UAP56. Mol. Biol. Rep. 39, 1935\u20131942 (2012).","journal-title":"Mol. Biol. Rep."},{"key":"2305_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26653-6","volume":"12","author":"T Mahlokozera","year":"2021","unstructured":"Mahlokozera, T. et al. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. Nat. Commun. 12, 6321 (2021).","journal-title":"Nat. Commun."},{"key":"2305_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04208-3","volume":"12","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53. Cell Death Dis. 12, 945 (2021).","journal-title":"Cell Death Dis."},{"key":"2305_CR42","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1101\/gad.1302205","volume":"19","author":"S Masuda","year":"2005","unstructured":"Masuda, S. et al. Recruitment of the human TREX complex to mRNA during splicing. Genes Dev. 19, 1512\u20131517 (2005).","journal-title":"Genes Dev."},{"key":"2305_CR43","doi-asserted-by":"publisher","first-page":"8947","DOI":"10.2147\/CMAR.S225606","volume":"11","author":"X Fan","year":"2019","unstructured":"Fan, X. et al. Genetic And Epigenetic Regulation Of E-Cadherin Signaling In Human Hepatocellular Carcinoma. Cancer Manag. Res. 11, 8947\u20138963 (2019).","journal-title":"Cancer Manag. Res."},{"key":"2305_CR44","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2024.10852","volume":"332","author":"CE Ryan","year":"2024","unstructured":"Ryan, C. E. et al. Germline CDH1 Variants and Lifetime Cancer Risk. JAMA 332, 722\u2013729 (2024).","journal-title":"JAMA"},{"key":"2305_CR45","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1038\/onc.2011.117","volume":"30","author":"JC Cheng","year":"2011","unstructured":"Cheng, J. C., Auersperg, N. & Leung, P. C. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells. Oncogene 30, 3930\u20133942 (2011).","journal-title":"Oncogene"},{"key":"2305_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-016-0502-x","volume":"15","author":"SJ Serrano-Gomez","year":"2016","unstructured":"Serrano-Gomez, S. J., Maziveyi, M. & Alahari, S. K. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol. Cancer 15, 18 (2016).","journal-title":"Mol. Cancer"},{"key":"2305_CR47","first-page":"ss","volume":"11","author":"Z Huang","year":"2024","unstructured":"Huang, Z. et al. Oxidative Stress Promotes Liver Cancer Metastasis via RNF25-Mediated E-Cadherin Protein Degradation. Adv. Sci. 11, ss (2024).","journal-title":"Adv. Sci."},{"key":"2305_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","volume":"46","author":"T Efferth","year":"2017","unstructured":"Efferth, T. From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Semin. Cancer Biol. 46, 65\u201383 (2017).","journal-title":"Semin. Cancer Biol."},{"key":"2305_CR49","first-page":"5995","volume":"37","author":"S Slezakova","year":"2017","unstructured":"Slezakova, S. & Ruda-Kucerova, J. Anticancer Activity of Artemisinin and its Derivatives. Anticancer Res. 37, 5995\u20136003 (2017).","journal-title":"Anticancer Res."},{"key":"2305_CR50","doi-asserted-by":"publisher","first-page":"155274","DOI":"10.1016\/j.phymed.2023.155274","volume":"123","author":"H Strik","year":"2024","unstructured":"Strik, H., Efferth, T. & Kaina, B. Artesunate in glioblastoma therapy: Case reports and review of clinical studies. Phytomedicine 123, 155274 (2024).","journal-title":"Phytomedicine"},{"key":"2305_CR51","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/15548627.2023.2261758","volume":"20","author":"Z Ma","year":"2024","unstructured":"Ma, Z. et al. Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy. Autophagy 20, 541\u2013556 (2024).","journal-title":"Autophagy"},{"key":"2305_CR52","doi-asserted-by":"publisher","first-page":"114941","DOI":"10.1016\/j.bcp.2022.114941","volume":"198","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Dihydroartemisinin and artesunate inhibit aerobic glycolysis via suppressing c-Myc signaling in non-small cell lung cancer. Biochem. Pharmacol. 198, 114941 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"2305_CR53","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/ijc.25315","volume":"127","author":"SA Rasheed","year":"2010","unstructured":"Rasheed, S. A., Efferth, T., Asangani, I. A. & Allgayer, H. First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int. J. Cancer 127, 1475\u20131485 (2010).","journal-title":"Int. J. Cancer"},{"key":"2305_CR54","doi-asserted-by":"publisher","first-page":"e22837","DOI":"10.1096\/fj.202201801R","volume":"37","author":"Q Li","year":"2023","unstructured":"Li, Q. et al. ZNF32 prevents the activation of cancer-associated fibroblasts through negative regulation of TGFB1 transcription in breast cancer. FASEB J. 37, e22837 (2023).","journal-title":"FASEB J."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02305-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:03:21Z","timestamp":1752620601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02305-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2305"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02305-9","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"221"}}